Discovery of amide-functionalized benzimidazolium salts as potent α-glucosidase inhibitors
α-Glucosidase inhibitors (AGIs) are used as medicines for the treatment of diabetes mellitus. The α-Glucosidase enzyme is present in the small intestine and is responsible for the breakdown of carbohydrates into sugars. The process results in an increase in blood sugar levels. AGIs slow down the dig...
發表在: | Molecules |
---|---|
主要作者: | 2-s2.0-85112329694 |
格式: | Article |
語言: | English |
出版: |
MDPI AG
2021
|
在線閱讀: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112329694&doi=10.3390%2fmolecules26164760&partnerID=40&md5=bc2b6a585ad05ed6048fce3d82640811 |
相似書籍
-
Development of benzimidazolium salt-based cubosome hydrogel for topical treatment of burns
由: 2-s2.0-85217012735
出版: (2025) -
Synthesis of Indole Based Sulfonamide Derivatives as potent inhibitors of α-glucosidase and α-amylase in management of type-II diabetes
由: 2-s2.0-85185155619
出版: (2024) -
Novel quinoline derivatives as potent in vitro α-glucosidase inhibitors: In silico studies and SAR predictions
由: 2-s2.0-84943771420
出版: (2015) -
Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions
由: 2-s2.0-84942794211
出版: (2015) -
Synthesis and biological evaluation of novel coumarin derivatives bearing sulfonamide moiety as potent α-glucosidase inhibitors
由: Alsukor A.; Inayatsyah N.A.; Ridhwan M.J.M.; Kasim N.; Imran S.
出版: (2025)